🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › Ohio

Etid klinik pou Dyabèt Tip 2 nan Ohio

41 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan Ohio.

Vil nan Ohio

Tèks ofisyèl etid la (Anglè)

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Diabetes & Endocrinology Associates of Stark County, Canton
  • Advanced Medical Research - Maumee, Maumee
  • New Venture Medical Research, Wadsworth
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • The Christ Hospital, Cincinnati
  • Velocity Clinical Research-Cincinnati-69044, Cincinnati
  • Centricity Research-Columbus-68879, Columbus
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

  • Advanced Medical Research, Maumee
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07817251

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE

  • The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Sep 29, 2026 · NCT05909046

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Summa Health, Akron
Ap rekriteVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

  • Ohio Clinical Trials, Columbus
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07399678

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • Midwest Eye Center, Cincinnati
  • Velocity Clinical Research, Mt. Auburn, Cincinnati
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Care Access - Lima, Lima
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Kent
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Cincinnati
  • AURORA-2 Clinical Site, Cleveland
  • AURORA-2 Clinical Site, Columbus
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Remington Davis Inc, Columbus
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Providence Health Partners-Center for Clinical Research, Dayton
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

  • Providence Center for Clinical Research, Dayton
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 11, 2026 · NCT07415954

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Velocity Clinical Research, Cincinnati, Mt. Auburn, Cincinnati
  • Velocity Clinical Research - Cincinnati, Blue Ash, Cincinnati
  • Endocrinology Associates, Inc, Columbus
  • ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • PriMED Clinical Research, Dayton
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Velocity Clinical Research - Cincinnati, Cincinnati
  • Velocity Clinical Research - Springdale, Cincinnati
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Beachwood
  • Research Site, Maumee
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662109

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

  • Research Site, Maumee
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07606066

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

  • Centricity Research Columbus, Columbus
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT07527650

NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes

  • The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Aug 14, 2026 · NCT07560813

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • Childrens Hospital Medical Center, Cincinnati
  • Cleveland Clinic Childrens Outpatient Center, Cleveland
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Aug 7, 2026 · NCT06739122

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes

  • Cleveland Clinic Foundation, Cleveland
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT06046833

Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching

  • The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Jun 29, 2026 · NCT05662462

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

  • Diabetes and Endocrinology Associates of Stark County, Canton
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jun 15, 2026 · NCT07502508

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

  • Cincinnati Children's Hospital, Cincinnati
  • Nationwide Children's Hospital, Columbus
Ap rekriteEtid obsèvasyon
Laj 8 a 15 · Tout sèks · Mizajou May 7, 2026 · NCT06525259

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

  • The Ohio State University, Columbus
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 1, 2026 · NCT06251323

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

  • Diabetes & Endocrinology Associates of Stark County, Inc., Canton
  • Advanced Medical Research, Maumee
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07546929

Using Virtual Reality to Improve Medical Training

  • Ohio University, Athens
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 21, 2026 · NCT07542834

Effects of Ketone Ester Consumption on Exercise Tolerance and Cardiac Function

  • The Ross Heart Hospital, Columbus
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Apr 3, 2026 · NCT06078683

Food and Fitness With Medicine (FFWM)

  • Ohio State East Hospital, Columbus
  • Martha Morehouse, Columbus
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Feb 23, 2026 · NCT07027995

Effect of Arestin-Enhanced SRP on Periodontal and Glycemic Outcomes in Diabetics

  • Case Western Reserve University, Cleveland
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Feb 19, 2026 · NCT07298057

Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Ap rekriteFaz 2
Laj 10 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT07029009

Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention

  • The Ohio State University, Columbus
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Oct 6, 2025 · NCT06055036

Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)

  • The Ohio State University Wexner Medical Center, Columbus
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2025 · NCT05472441

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

  • Lower Extremity Institute of Research and Therapy, Boardman
  • Brock Liden DPM, Circleville
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 10, 2025 · NCT06681428

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.